Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Expanded AngioSeal Supply Deal Heightens Investor Interest In Kensey Nash

This article was originally published in The Gray Sheet

Executive Summary

Kensey Nash's ability to convince investors that AngioSeal will generate sales exceeding $75 mil. over the life of a multi-year contract with St. Jude Medical helped the supplier's stock price swell by more than 11% during June

You may also be interested in...

Angio-Seal deal

Kensey Nash will commercialize new proprietary collagen technologies through incorporation into St. Jude Medical's vascular closure device under a five-year component supply contract starting June 30. Kensey will remain the sole collagen provider for Angio-Seal. The agreement replaces a previous contract that expires in November...

Cyberonics Awaits Possible Takeover Bid; Stock Up Nearly 18% In March

Cyberonics stock produced strong returns for investors in March as speculation about a possible takeover bid increased

Kensey Nash Touts Prospects For TriActiv Embolic Protection Device

Kensey Nash believes the embolic protection market for saphenous vein graft procedures will double to more than $200 mil. in the next few years as physicians use distal protection to diminish their exposure to litigation

Related Content




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts